Android app on Google Play

Rodman & Renshaw Hikes Price Target On Adventrx Pharmaceuticals (ANX) to $16

June 20, 2011 9:44 AM EDT Send to a Friend
Get Alerts ANX Hot Sheet
Price: $0.73 --0%

Rating Summary:
    2 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 9 | Down: 11 | New: 43
Trade ANX Now!
Join SI Premium – FREE
Rodman & Renshaw raised their price target on Adventrx Pharmaceuticals (NYSE: ANX) from $4.50 to $16 while maintaining their Market Outperform rating.

Shares are on the move following the price target hike. Last trading up 9.7% to $2.60.

For more ratings news on Adventrx Pharmaceuticals click here and for the rating history of Adventrx Pharmaceuticals click here.

You May Also Be Interested In

Related Categories

Analyst Comments

Related Entities

Rodman & Renshaw

Add Your Comment